Multiple sclerosis continuity care

Ongoing management of disease modifying therapies

1. Interferons (Avonex, Betaseron, Extavia, Rebif)
2. Glatimar Acetate (Copaxone)
3. Natalizumab (Tysabri)
4. Fingolimod (Gilenya)
5. Teriflunomide (Aubagio)

Symptomatic management of MS symptoms, including

1. Ambulatory dysfunction
2. Spasticity
3. Fatigue
4. Neurogenic bladder
5. Cognitive dysfunction

Therapeutic management evaluations

1. Injection training
2. Risk stratification with Tysabri
3. First dose observation with Gilenya

Consultative second opinion services

Neuropsychological evaluation and management

Physical and occupational therapy

Social work services

Community support programs